---
layout: default
title: Adaptable Cardiovascular Disease Risk Prediction from Heterogeneous Data using Large Language Models
---

# Adaptable Cardiovascular Disease Risk Prediction from Heterogeneous Data using Large Language Models

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2505.24655" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2505.24655v1</a>
  <a href="https://arxiv.org/pdf/2505.24655.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2505.24655v1" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2505.24655v1', 'Adaptable Cardiovascular Disease Risk Prediction from Heterogeneous Data using Large Language Models')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Frederike LÃ¼beck, Jonas Wildberger, Frederik TrÃ¤uble, Maximilian Mordig, Sergios Gatidis, Andreas Krause, Bernhard SchÃ¶lkopf

**åˆ†ç±»**: cs.AI, cs.LG

**å‘å¸ƒæ—¥æœŸ**: 2025-05-30

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºAdaCVDä»¥è§£å†³å¿ƒè¡€ç®¡ç–¾ç—…é£é™©é¢„æµ‹ä¸­çš„æ•°æ®å¼‚è´¨æ€§é—®é¢˜**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±ä¹ï¼šå…·èº«å¤§æ¨¡å‹ (Embodied Foundation Models)**

**å…³é”®è¯**: `å¿ƒè¡€ç®¡ç–¾ç—…` `é£é™©é¢„æµ‹` `å¤§å‹è¯­è¨€æ¨¡å‹` `æ•°æ®å¼‚è´¨æ€§` `ä¸´åºŠå†³ç­–æ”¯æŒ` `æœºå™¨å­¦ä¹ ` `ä¸ªæ€§åŒ–åŒ»ç–—`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. ç°æœ‰å¿ƒè¡€ç®¡ç–¾ç—…é£é™©é¢„æµ‹æ¨¡å‹è¿‡äºç®€åŒ–æ‚£è€…ä¿¡æ¯ï¼Œéš¾ä»¥é€‚åº”çœŸå®ä¸–ç•Œçš„ä¸´åºŠå®è·µã€‚
2. æå‡ºçš„AdaCVDæ¡†æ¶åŸºäºå¤§å‹è¯­è¨€æ¨¡å‹ï¼Œèƒ½å¤Ÿçµæ´»æ•´åˆå¤šæ ·åŒ–çš„æ‚£è€…ä¿¡æ¯å’Œæ•°æ®ç±»å‹ã€‚
3. å®éªŒç»“æœæ˜¾ç¤ºï¼ŒAdaCVDåœ¨å„ç±»äººç¾¤ä¸­è¡¨ç°å‡ºè‰²ï¼Œè¶…è¶Šäº†ä¼ ç»Ÿé£é™©è¯„åˆ†å’Œæœºå™¨å­¦ä¹ æ–¹æ³•ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

å¿ƒè¡€ç®¡ç–¾ç—…ï¼ˆCVDï¼‰é£é™©é¢„æµ‹æ¨¡å‹å¯¹äºè¯†åˆ«é«˜é£é™©ä¸ªä½“å’ŒæŒ‡å¯¼é¢„é˜²æªæ–½è‡³å…³é‡è¦ã€‚ç„¶è€Œï¼Œç°æœ‰æ¨¡å‹åœ¨å®é™…ä¸´åºŠåº”ç”¨ä¸­é¢ä¸´æŒ‘æˆ˜ï¼Œè¿‡äºç®€åŒ–æ‚£è€…ç‰¹å¾ï¼Œä¾èµ–å›ºå®šè¾“å…¥æ¨¡å¼ï¼Œå¹¶å¯¹åˆ†å¸ƒå˜åŒ–æ•æ„Ÿã€‚æœ¬æ–‡å¼€å‘äº†AdaCVDï¼Œä¸€ä¸ªåŸºäºå¤§å‹è¯­è¨€æ¨¡å‹çš„é€‚åº”æ€§CVDé£é™©é¢„æµ‹æ¡†æ¶ï¼Œç»è¿‡å¯¹è¶…è¿‡50ä¸‡åUK Biobankå‚ä¸è€…çš„å¹¿æ³›å¾®è°ƒã€‚åœ¨åŸºå‡†æ¯”è¾ƒä¸­ï¼ŒAdaCVDè¶…è¶Šäº†æ—¢æœ‰é£é™©è¯„åˆ†å’Œæ ‡å‡†æœºå™¨å­¦ä¹ æ–¹æ³•ï¼Œè¾¾åˆ°äº†æœ€å…ˆè¿›çš„æ€§èƒ½ã€‚å®ƒé¦–æ¬¡åœ¨ä¸‰ä¸ªç»´åº¦ä¸Šè§£å†³äº†å…³é”®ä¸´åºŠæŒ‘æˆ˜ï¼šçµæ´»æ•´åˆå…¨é¢è€Œå¤šå˜çš„æ‚£è€…ä¿¡æ¯ï¼›æ— ç¼ç»“åˆç»“æ„åŒ–æ•°æ®å’Œéç»“æ„åŒ–æ–‡æœ¬ï¼›å¹¶èƒ½åœ¨ä½¿ç”¨æœ€å°‘é¢å¤–æ•°æ®çš„æƒ…å†µä¸‹å¿«é€Ÿé€‚åº”æ–°æ‚£è€…ç¾¤ä½“ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šæœ¬æ–‡æ—¨åœ¨è§£å†³å¿ƒè¡€ç®¡ç–¾ç—…é£é™©é¢„æµ‹ä¸­ç°æœ‰æ¨¡å‹çš„ä¸è¶³ï¼Œç‰¹åˆ«æ˜¯å¯¹æ‚£è€…ç‰¹å¾çš„è¿‡åº¦ç®€åŒ–å’Œå¯¹æ•°æ®åˆ†å¸ƒå˜åŒ–çš„æ•æ„Ÿæ€§ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šAdaCVDæ¡†æ¶é€šè¿‡å¤§å‹è¯­è¨€æ¨¡å‹çš„å¾®è°ƒï¼Œçµæ´»æ•´åˆç»“æ„åŒ–å’Œéç»“æ„åŒ–æ•°æ®ï¼Œé€‚åº”ä¸åŒæ‚£è€…ç¾¤ä½“çš„éœ€æ±‚ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šè¯¥æ¡†æ¶åŒ…æ‹¬æ•°æ®é¢„å¤„ç†ã€æ¨¡å‹è®­ç»ƒã€é£é™©è¯„ä¼°å’Œç»“æœè¾“å‡ºå››ä¸ªä¸»è¦æ¨¡å—ï¼Œèƒ½å¤Ÿå¤„ç†å¤šç§æ•°æ®ç±»å‹ã€‚

**å…³é”®åˆ›æ–°**ï¼šAdaCVDé¦–æ¬¡å®ç°äº†å¯¹å¤šæ ·åŒ–æ‚£è€…ä¿¡æ¯çš„çµæ´»æ•´åˆï¼Œå¹¶èƒ½åœ¨æœ€å°‘æ•°æ®æƒ…å†µä¸‹å¿«é€Ÿé€‚åº”æ–°ç¾¤ä½“ï¼Œæ˜¾è‘—æå‡äº†æ¨¡å‹çš„é€‚ç”¨æ€§ã€‚

**å…³é”®è®¾è®¡**ï¼šåœ¨æ¨¡å‹è®¾è®¡ä¸­ï¼Œé‡‡ç”¨äº†ç‰¹å®šçš„æŸå¤±å‡½æ•°ä»¥ä¼˜åŒ–é£é™©é¢„æµ‹ç²¾åº¦ï¼Œå¹¶åœ¨ç½‘ç»œç»“æ„ä¸Šè¿›è¡Œäº†é’ˆå¯¹æ€§è°ƒæ•´ï¼Œä»¥æé«˜å¯¹éç»“æ„åŒ–æ–‡æœ¬çš„å¤„ç†èƒ½åŠ›ã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

åœ¨åŸºå‡†æµ‹è¯•ä¸­ï¼ŒAdaCVDçš„æ€§èƒ½è¶…è¶Šäº†ä¼ ç»Ÿçš„é£é™©è¯„åˆ†å’Œæ ‡å‡†æœºå™¨å­¦ä¹ æ–¹æ³•ï¼Œæ˜¾ç¤ºå‡ºåœ¨ä¸åŒäººå£ç»Ÿè®¡ã€ç¤¾ä¼šç»æµå’Œä¸´åºŠäºšç»„ä¸­çš„ç¨³å¥è¡¨ç°ï¼Œå°¤å…¶æ˜¯åœ¨ä»£è¡¨æ€§ä¸è¶³çš„ç¾¤ä½“ä¸­ï¼Œå±•ç°äº†æ˜¾è‘—çš„æå‡å¹…åº¦ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

AdaCVDæ¡†æ¶çš„æ½œåœ¨åº”ç”¨é¢†åŸŸåŒ…æ‹¬ä¸´åºŠå†³ç­–æ”¯æŒç³»ç»Ÿã€ä¸ªæ€§åŒ–åŒ»ç–—å’Œå…¬å…±å«ç”Ÿç›‘æµ‹ã€‚å…¶çµæ´»æ€§å’Œé€‚åº”æ€§ä½¿å…¶èƒ½å¤Ÿåœ¨åŠ¨æ€çš„åŒ»ç–—ç¯å¢ƒä¸­æä¾›æ›´ç²¾å‡†çš„é£é™©è¯„ä¼°ï¼Œå…·æœ‰é‡è¦çš„å®é™…ä»·å€¼å’Œæœªæ¥å½±å“ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Cardiovascular disease (CVD) risk prediction models are essential for identifying high-risk individuals and guiding preventive actions. However, existing models struggle with the challenges of real-world clinical practice as they oversimplify patient profiles, rely on rigid input schemas, and are sensitive to distribution shifts. We developed AdaCVD, an adaptable CVD risk prediction framework built on large language models extensively fine-tuned on over half a million participants from the UK Biobank. In benchmark comparisons, AdaCVD surpasses established risk scores and standard machine learning approaches, achieving state-of-the-art performance. Crucially, for the first time, it addresses key clinical challenges across three dimensions: it flexibly incorporates comprehensive yet variable patient information; it seamlessly integrates both structured data and unstructured text; and it rapidly adapts to new patient populations using minimal additional data. In stratified analyses, it demonstrates robust performance across demographic, socioeconomic, and clinical subgroups, including underrepresented cohorts. AdaCVD offers a promising path toward more flexible, AI-driven clinical decision support tools suited to the realities of heterogeneous and dynamic healthcare environments.

